coronavirus treatment

Monoclonal antibodies to prevent severe COVID-19 aren't being used as widely as expected. Medical staff shortages and patient transportation problems are two of the reasons.

Speaking in a video released Wednesday morning, Gov. Ron DeSantis announced plans for the distribution of possible COVID-19 vaccines.

The drug is a combo of two antibodies to enhance the chances it will prove effective. It's an experimental medicine that President Trump was given when he was sickened last month.

NPR's Rachel Martin talks to Dr. Anthony Fauci, the country's top infectious disease expert, about promising results for vaccine candidates and his advice for staying safe during the holidays.

Eli Lilly's monoclonal antibody will be available to people 65 or older or those with underlying health conditions. Supplies will be short, and allocating the medicine will be a challenge.

The federal government plans to distribute 300,000 doses of the drug at no cost, but that doesn't mean treatment will be free. Intravenous infusion charges can run more than $1,000.

President Donald Trump is among those who have been treated with remdesivir, and FDA-approval could widen access to more patients.

A vaccine will only work if a lot of people can get immunized. State health officials are working furiously to design outreach and distribution plans, with little clarity from the federal government.

Federal, Florida and local law enforcement officials who have recovered from COVID-19 are partnering with OneBlood to raise awareness about plasma…

An NPR investigation has identified a web of more than 30 medical practices and compounding pharmacies in over a dozen states that have made claims about thymosin alpha-1 online and on social media.